SEHK:1858

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Beijing Chunlizhengda Medical Instruments

Executive Summary

Beijing Chunlizhengda Medical Instruments Co., Ltd., an orthopedic medical device company, engages in the research and development, production, and sale of surgical implants, instruments, and related products in the People’s Republic of China. More Details


Snowflake Analysis

Flawless balance sheet with solid track record.


Similar Companies

Share Price & News

How has Beijing Chunlizhengda Medical Instruments's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 1858 is more volatile than 75% of Hong Kong stocks over the past 3 months, typically moving +/- 12% a week.

Volatility Over Time: 1858's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of Hong Kong stocks.


Market Performance


7 Day Return

11.8%

1858

4.3%

HK Medical Equipment

-1.0%

HK Market


1 Year Return

12.0%

1858

97.7%

HK Medical Equipment

9.0%

HK Market

Return vs Industry: 1858 underperformed the Hong Kong Medical Equipment industry which returned 95.9% over the past year.

Return vs Market: 1858 exceeded the Hong Kong Market which returned 9.8% over the past year.


Shareholder returns

1858IndustryMarket
7 Day11.8%4.3%-1.0%
30 Day-33.5%0.02%5.9%
90 Day-49.5%-13.0%7.5%
1 Year12.0%12.0%98.9%97.7%13.4%9.0%
3 Year906.6%864.4%175.6%168.4%2.4%-8.3%
5 Year748.3%695.3%257.2%239.6%36.9%13.8%

Long-Term Price Volatility Vs. Market

How volatile is Beijing Chunlizhengda Medical Instruments's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Beijing Chunlizhengda Medical Instruments undervalued compared to its fair value and its price relative to the market?

26.24x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: 1858 (HK$21.95) is trading above our estimate of fair value (HK$17.55)

Significantly Below Fair Value: 1858 is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: 1858 is good value based on its PE Ratio (26.2x) compared to the HK Medical Equipment industry average (29.6x).

PE vs Market: 1858 is poor value based on its PE Ratio (26.2x) compared to the Hong Kong market (11.1x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 1858's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 1858 is overvalued based on its PB Ratio (7x) compared to the HK Medical Equipment industry average (4.1x).


Next Steps

Future Growth

How is Beijing Chunlizhengda Medical Instruments forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

21.2%

Forecasted annual revenue growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 1858's forecast earnings growth is above the savings rate (1.6%).

Earnings vs Market: Insufficient data to determine if 1858's earnings are forecast to grow faster than the Hong Kong market

High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 1858's revenue (21.2% per year) is forecast to grow faster than the Hong Kong market (13.6% per year).

High Growth Revenue: 1858's revenue (21.2% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 1858's Return on Equity is forecast to be high in 3 years time (27.7%)


Next Steps

Past Performance

How has Beijing Chunlizhengda Medical Instruments performed over the past 5 years?

39.4%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 1858 has a high level of non-cash earnings.

Growing Profit Margin: 1858's current net profit margins (27.5%) are higher than last year (24.9%).


Past Earnings Growth Analysis

Earnings Trend: 1858's earnings have grown significantly by 39.4% per year over the past 5 years.

Accelerating Growth: 1858's earnings growth over the past year (48.3%) exceeds its 5-year average (39.4% per year).

Earnings vs Industry: 1858 earnings growth over the past year (48.3%) exceeded the Medical Equipment industry 17.7%.


Return on Equity

High ROE: 1858's Return on Equity (26.8%) is considered high.


Next Steps

Financial Health

How is Beijing Chunlizhengda Medical Instruments's financial position?


Financial Position Analysis

Short Term Liabilities: 1858's short term assets (CN¥991.7M) exceed its short term liabilities (CN¥266.8M).

Long Term Liabilities: 1858's short term assets (CN¥991.7M) exceed its long term liabilities (CN¥90.2M).


Debt to Equity History and Analysis

Debt Level: 1858 is debt free.

Reducing Debt: 1858 has not had any debt for past 5 years.

Debt Coverage: 1858 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 1858 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Next Steps

Dividend

What is Beijing Chunlizhengda Medical Instruments's current dividend yield, its reliability and sustainability?

1.37%

Forecast Dividend Yield


Dividend Yield vs Market

Notable Dividend: Unable to evaluate 1858's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate 1858's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if 1858's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 1858's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: 1858 is not paying a notable dividend for the Hong Kong market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of 1858's dividend in 3 years as they are not forecast to pay a notable one for the Hong Kong market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

5.8yrs

Average management tenure


CEO

Chunbao Shi (50 yo)

10.25yrs

Tenure

CN¥1,336,369

Compensation

Mr. Chunbao Shi has been General Manager and Executive Chairman of the Board for Beijing Chunlizhengda Medical Instruments Co., Ltd. since September 2010. Mr. Shi has been Sales & Marketing Director of Bei...


CEO Compensation Analysis

Compensation vs Market: Chunbao's total compensation ($USD204.27K) is below average for companies of similar size in the Hong Kong market ($USD475.11K).

Compensation vs Earnings: Chunbao's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Chunbao Shi
Executive Chairman10.25yrsCN¥1.34m32.87%
CN¥ 2.5b
Shujun Yue
Deputy GM & Executive Director10.25yrsCN¥1.06m27.6%
CN¥ 2.1b
Yumei Liu
Chief Financial Officer2.42yrsno datano data
Fengbao Xie
Executive Director0.50yrCN¥66.07kno data
Pui-Sum Ip
Company Secretary5.75yrsno datano data

5.8yrs

Average Tenure

48yo

Average Age

Experienced Management: 1858's management team is seasoned and experienced (5.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Chunbao Shi
Executive Chairman10.25yrsCN¥1.34m32.87%
CN¥ 2.5b
Shujun Yue
Deputy GM & Executive Director10.25yrsCN¥1.06m27.6%
CN¥ 2.1b
Fengbao Xie
Executive Director0.50yrCN¥66.07kno data
Tak Shing Wong
Independent Non-Executive Director0.25yrno datano data
Lanlan Zhang
Employee Supervisor10.25yrsCN¥34.47kno data
Changyin Ge
Independent Non-Executive Director3.5yrsCN¥100.00kno data
Jinyong Zhan
Chairman of the Board of Supervisorsno datano datano data
Xiaohui Pei
Supervisor4.42yrsno datano data
Xin Wang
Non-Executive Director0.50yrno datano data
Jie Weng
Independent Non-Executive Director0.50yrno datano data
Jie Zhang
Shareholder Representative Supervisor0.25yrno datano data

2.0yrs

Average Tenure

49yo

Average Age

Experienced Board: 1858's board of directors are not considered experienced ( 2 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Beijing Chunlizhengda Medical Instruments Co., Ltd.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Beijing Chunlizhengda Medical Instruments Co., Ltd.
  • Ticker: 1858
  • Exchange: SEHK
  • Founded: 1998
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: HK$7.609b
  • Shares outstanding: 345.85m
  • Website: https://www.clzd.com/tc/index.php

Number of Employees


Location

  • Beijing Chunlizhengda Medical Instruments Co., Ltd.
  • No. 10 Xinmi Xi Er Road
  • Southern District of Tongzhou
  • Beijing
  • Beijing Province
  • China

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
1858SEHK (The Stock Exchange of Hong Kong Ltd.)YesForeign Shares-Foreign ListedHKHKDMar 2015

Biography

Beijing Chunlizhengda Medical Instruments Co., Ltd., an orthopedic medical device company, engages in the research and development, production, and sale of surgical implants, instruments, and related produ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/12/04 10:15
End of Day Share Price2020/12/04 00:00
Earnings2020/06/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.